Effectiveness and Safety of Apremilast in Immune Checkpoint Inhibitor〢ssociated Psoriasis: A Retrospective Multicenter Study From theEADVTask Force “Dermatology for Cancer Patients”

Post time 7 day(s) ago

journal：International Journal of Dermatology

Authors：Dimitra Koumaki; Ioannis〢lexios Koumprentziotis; Zoe Apalla; Vincent Sibaud; Michela Valeria Rita Starace; Luca Rapparini; Sonia Segura; Gloria Juan〤arpena; Mar Blanes㎝artínez; Chrysa Oikonomou; Florentina Delli; Elena Sotiriou; Ander Mayor; Joaquín López Robles; Monika Arenbergerová; Vasiliki Nikolaou

Published date：--

DOI：10.1111/ijd.70592

PDF link：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ijd.70592

Article link：https://doi.org/10.1111/ijd.70592

Article Source：Wiley。

Remark：Please provide article pdf on urgent basis

Post time 7 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Wiley] Effectiveness and Safety of Apremilast in Immune Checkpoint Inhibitor〢ssociated Psoriasis: A Retrospective Multicenter Study From theEADVTask Force “Dermatology for Cancer Patients”

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Wiley] Effectiveness and Safety of Apremilast in Immune Checkpoint Inhibitor〢ssociated Psoriasis: A Retrospective Multicenter Study From theEADVTask Force “Dermatology for Cancer Patients” Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Wiley] Effectiveness and Safety of Apremilast in Immune Checkpoint Inhibitor〢ssociated Psoriasis: A Retrospective Multicenter Study From theEADVTask Force “Dermatology for Cancer Patients”